Lucyamma Thalody, MD
Internal Medicine · Elizabeth, NJNPI 1790892941
Payments from drug & device makers
Across 64 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$163
- Optinose US, Inc.$98
- Merck$71
- GSK$67
- Novartis$62
- Boehringer Ingelheim$53
- plus $416 from 18 others
What the payments were for
- Food & beverage$929100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 10 | $163 |
| Optinose US, Inc. | 7 | $98 |
| Merck | 5 | $71 |
| GSK | 5 | $67 |
| Novartis | 4 | $62 |
| Boehringer Ingelheim | 4 | $53 |
| Abbott | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| AstraZeneca | 3 | $38 |
| Gilead | 2 | $31 |
| Astellas Pharma US Inc | 2 | $29 |
| Amgen | 2 | $28 |
| Johnson & Johnson | 2 | $27 |
| Novo Nordisk | 2 | $25 |
| Dexcom, Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Mannkind Corporation | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Phadia US Inc. | 1 | $11 |
How this compares
$929 in reported general payments places this provider in the 65th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $217 |
| Atorvastatin Calcium | 17 | $151 |
| Losartan Potassium | 12 | $131 |
| Montelukast Sodium | 13 | $97 |
| Potassium Chloride | 12 | $94 |
| Metformin Hcl | 11 | $88 |
| Amlodipine Besylate | 18 | $81 |
| Azithromycin | 16 | $35 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Elizabeth
- Francisco MunozElizabeth$303K
- Sanjiv SharmaToms River$33.9M
- Jeffrey CarsonNew Brunswick$13.8M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Samar HameedLivingston$3.6M
- Jane RohlfTrenton$2.7M
- Mohammed NisarEdison$2.6M
- Michael CasserNew Milford$2.2M
- Sumitha ReddyHamilton$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.